CME Group Inc. (NASDAQ:CME) Stock Position Decreased by Tower Bridge Advisors

Tower Bridge Advisors trimmed its stake in CME Group Inc. (NASDAQ:CME) by 0.5% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,751 shares of the financial services provider’s stock after selling 133 shares during the quarter. Tower Bridge Advisors’ holdings in CME Group were worth $5,903,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Harbor Capital Advisors Inc. boosted its stake in CME Group by 0.6% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC lifted its holdings in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after purchasing an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich boosted its position in shares of CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after buying an additional 50 shares during the period. Zions Bancorporation N.A. grew its holdings in shares of CME Group by 3.7% during the third quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock valued at $338,000 after buying an additional 54 shares in the last quarter. Finally, Quent Capital LLC grew its holdings in shares of CME Group by 10.2% during the third quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after buying an additional 55 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Price Performance

Shares of NASDAQ:CME opened at $225.28 on Friday. The stock has a market capitalization of $81.18 billion, a P/E ratio of 23.69, a P/E/G ratio of 5.20 and a beta of 0.55. The business has a 50-day moving average of $222.62 and a two-hundred day moving average of $210.37. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company earned $2.25 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. On average, equities research analysts predict that CME Group Inc. will post 10.22 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. The ex-dividend date is Monday, December 9th. CME Group’s dividend payout ratio is currently 48.37%.

Insider Activity at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of the firm’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at $1,652,298. This trade represents a 15.89 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Martin J. Gepsman sold 400 shares of CME Group stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 17th. The Goldman Sachs Group raised their price target on shares of CME Group from $195.00 to $198.00 and gave the stock a “sell” rating in a report on Thursday, October 3rd. Piper Sandler boosted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a research report on Monday, October 28th. TD Cowen started coverage on shares of CME Group in a research report on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $224.47.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.